Compare Msci Inc (MSCI) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Msci Inc vs Twist Bioscience Corp — how do they compare? Msci Inc trades at $562 (market cap $40.84B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Msci Inc is far larger — about 5.3× Twist Bioscience Corp's market cap, and Msci Inc pays a 1.46% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| MSCI | TWST | |
|---|---|---|
Market Cap | $40.84B | $7.72B |
Sector | Financials | Health |
52-Week High | $643.83 | $124.88 |
52-Week Low | $511.84 | $24.16 |
Enterprise Value | $47.00B | $7.65B |
Dividend Yield | 1.46% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Msci Inc
MSCI describes its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. In addition, it boasts over $1 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. MSCI's all other segment was broken out into ESG and climate and private assets segments in 2021. In ESG and climate, MSCI provides ESG data to the investment industry. In the private assets side, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.
Read more on MSCI →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
